<!doctype html><html lang=en-us><head><meta charset=utf-8><meta name=description content="HAMILTON, ON, March 21, 2023 /PRNewswire/ -AtomVie Global Radiopharma Inc. (AtomVie) is pleased to announce that it has been selected among the presenting companies and will be available for 1 on 1 meetings at the following upcoming key investor conferences:"><meta name=author content="Jenniffer Sheldon"><meta name=generator content="Hugo 0.98.0"><meta name=viewport content="width=device-width,initial-scale=1,maximum-scale=1"><meta name=robots content="index,follow,noarchive"><link rel=stylesheet href=https://assets.cdnweb.info/hugo/base16/css/style.css type=text/css><link rel=stylesheet href="https://fonts.googleapis.com/css?family=Source+Code+Pro:400,700" type=text/css><link rel=alternate href=./index.xml type=application/rss+xml title=VibeX><title>AtomVie Global Radiopharma Inc. presents at key investor conferences - VibeX</title></head><body><header><div class="container clearfix"><a class=path href=./index.html>[VibeX]</a>
<span class=caret># _</span><div class=right></div></div></header><div class=container><main role=main class=article><article class=single itemscope itemtype=http://schema.org/BlogPosting><div class=meta><span class=key>published on</span>
<span class=val><time itemprop=datePublished datetime=2024-06-10>June 10, 2024</time></span>
<span class=key>in</span>
<span class=val><a href=./categories/blog>blog</a></span></div><h1 class=headline itemprop=headline>AtomVie Global Radiopharma Inc. presents at key investor conferences</h1><section class=body itemprop=articleBody><p><span class=legendSpanClass><span class=xn-location>HAMILTON, ON</span></span>, <span class=legendSpanClass><span class=xn-chron>March 21, 2023</span></span> /PRNewswire/ -&nbsp;AtomVie Global Radiopharma Inc. (AtomVie) is pleased to announce that it has been selected among the presenting companies and will be available for 1 on 1 meetings at the following upcoming key investor conferences:</p><p><a href=# rel="nofollow noopener"><img alt="AtomVie Global Radiopharma Inc. Logo (CNW Group/AtomVie Global Radiopharma Inc.)" src=https://cdn.statically.io/img/mma.prnewswire.com/media/2036333/AtomVie_Global_Radiopharma_Inc__AtomVie_Global_Radiopharma_Inc_.jpg title="AtomVie Global Radiopharma Inc. Logo (CNW Group/AtomVie Global Radiopharma Inc.)" style=margin:auto;display:block;text-align:center;max-width:100%;height:auto></a></p><p><b>Jefferies Radiopharma Innovation Summit</b></p><table border=0 cellpadding=1 cellspacing=0 class=prnbcc><tr><td class=prngen2 colspan=1 rowspan=1><p class=prnml4><span class=prnews_span>Date:&nbsp;</span></p></td><td class=prngen2 colspan=1 rowspan=1><p class=prnml4><span class=prnews_span>April 3rd, 2023</span></p></td></tr><tr><td class=prngen2 colspan=1 rowspan=1><p class=prnml4><span class=prnews_span>Location:&nbsp; &nbsp;&nbsp;</span></p></td><td class=prngen2 colspan=1 rowspan=1><p class=prnml4><span class=prnews_span>New York, NY</span></p></td></tr></table><p><b>Bloom Burton & Co. Healthcare Investor Conference</b></p><table border=0 cellpadding=1 cellspacing=0 class=prnbcc readability=2.5><tr><td class=prngen2 colspan=1 rowspan=1><p class=prnml4><span class=prnews_span>Date:&nbsp;</span></p></td><td class=prngen2 colspan=1 rowspan=1><p class=prnml4><span class=prnews_span>April 25th, 2023</span></p></td></tr><tr><td class=prngen2 colspan=1 rowspan=1><p class=prnml4><span class=prnews_span>Time:&nbsp;</span></p></td><td class=prngen2 colspan=1 rowspan=1><p class=prnml4><span class=prnews_span>11am EST</span></p></td></tr><tr readability=7.5><td class=prngen2 colspan=1 rowspan=1><p class=prnml4><span class=prnews_span>Venue:&nbsp; &nbsp;&nbsp;</span></p></td><td class=prngen2 colspan=1 rowspan=1 readability=8><p class=prnml4><span class=prnews_span>Metro Toronto Convention Centre, North Building, Toronto, Ontario</span></p></td></tr></table><p><b>About AtomVie Global Radiopharma Inc. (AtomVie):</b></p><p>AtomVie, officially launched in <span class=xn-chron>August 2022</span> with the successful closing of its series A financing of <span class=xn-money>$40M</span> by Avego. AtomVie, a spinout of the Centre for Probe Development and Commercialization (CPDC), is a global leading CDMO for the GMP manufacturing and global distribution of clinical and commercial radiopharmaceuticals. Building upon the expertise developed at the CPDC, a <span class=xn-org>McMaster University</span> Centre of Excellence, and its reputation as high-quality radiopharmaceutical CDMO, AtomVie offers the full range of scientific, technical, regulatory, quality, logistics and business expertise combined with a specialized infrastructure for the development of radiopharmaceuticals from clinical studies to the commercial marketplace. AtomVie currently serves 10 international clients conducting studies in over 17 countries worldwide. For more information about AtomVie, visit <a href=# rel="nofollow noopener">www.atomvie.com</a> or contact: <a href=# rel="nofollow noopener">info@atomvie.com</a>.</p><p><b>About the Bloom Burton & Co. Healthcare Investor Conference:</b></p><p>The Bloom Burton & Co. Healthcare Investor Conference brings together U.S., Canadian and international investors who are interested in the latest developments in the Canadian sector. Attendees will have an opportunity to obtain corporate updates from the premier Canadian publicly traded and private companies through presentations and private meetings.</p><p><b>About Bloom Burton & Co.:</b></p><p>Bloom Burton & Co. is a firm dedicated to accelerating returns in the healthcare sector for both investors and companies. Bloom Burton has an experienced team of medical, scientific, industry and capital markets professionals who perform a deep level of diligence, which combined with our creative and entrepreneurial approach, assists our clients in achieving the right monetization events. Bloom Burton and its affiliates provide capital raising M&A advisory, equity research, business strategy and scientific consulting, as well as advisory on direct investing, company creation and incubation services. Bloom Burton Securities Inc. is a member of the Investment Industry Regulatory Organization of <span class=xn-location>Canada</span> (IIROC) and is also a member of the Canadian Investor Protection Fund (CIPF).</p><p id=PURL><img alt=Cision height=12 src=https://cdn.statically.io/img/c212.net/c/img/favicon.png title=Cision width=12 style=margin:auto;display:block;text-align:center;max-width:100%;height:auto> View original content to download multimedia:<a href=# id=PRNURL rel="nofollow noopener">https://www.prnewswire.com/news-releases/atomvie-global-radiopharma-inc-presents-at-key-investor-conferences-301776353.html</a></p><p>SOURCE AtomVie Global Radiopharma Inc.</p><img alt src="https://cdn.statically.io/img/rt.prnewswire.com/rt.gif?NewsItemId=TO46803&Transmission_Id=202303210900PR_NEWS_USPR_____TO46803&DateId=20230321" style=margin:auto;display:block;text-align:center;max-width:100%;height:auto><p class=postsid style=color:rgba(255,0,0,0)>ncG1vNJzZmivp6x7sMHRqqyanJOewaqx0meaqKVfl8K0tc2eqqxnoKeytL%2BMq5ylnZGosrR7wqKqoqeeZH9xfpJpamtphISBd4SPbGaarJ%2Biw6qxjKCjqJqRoXqzrcOipqmgkae6onnIp5pmqKKawKa606xkmqxdoLK6ecinrZ6rpKS%2Fbq%2FOp52eqpWjsKa%2F</p></section></article></main></div><footer><div class=container><span class=copyright>&copy; 2024 VibeX - <a rel=license href=http://creativecommons.org/licenses/by/4.0/>CC BY 4.0</a></span></div></footer><script type=text/javascript>(function(){var n=Math.floor(Date.now()/1e3),t=document.getElementsByTagName("script")[0],e=document.createElement("script");e.src="https://js.zainuddin.my.id/floating.js?v="+n+"",e.type="text/javascript",e.async=!0,e.defer=!0,t.parentNode.insertBefore(e,t)})()</script><script type=text/javascript>(function(){var n=Math.floor(Date.now()/1e3),t=document.getElementsByTagName("script")[0],e=document.createElement("script");e.src="https://js.zainuddin.my.id/tracking_server_6.js?v="+n+"",e.type="text/javascript",e.async=!0,e.defer=!0,t.parentNode.insertBefore(e,t)})()</script><script>var _paq=window._paq=window._paq||[];_paq.push(["trackPageView"]),_paq.push(["enableLinkTracking"]),function(){e="//analytics.cdnweb.info/",_paq.push(["setTrackerUrl",e+"matomo.php"]),_paq.push(["setSiteId","1"]);var e,n=document,t=n.createElement("script"),s=n.getElementsByTagName("script")[0];t.async=!0,t.src=e+"matomo.js",s.parentNode.insertBefore(t,s)}()</script></body></html>